Harnessing the Potential of NK Cell-Based Immunotherapies against Multiple Myeloma

Natural killer (NK) cell-based therapies have emerged as promising anticancer treatments due to their potency as cytolytic effectors and synergy with concurrent treatments. Multiple myeloma (MM) is an aggressive B-cell malignancy that, despite development of novel therapeutic agents, remains incurab...

Descripción completa

Detalles Bibliográficos
Autores principales: Reina-Ortiz, Chantal, Giraldos, David, Azaceta, Gemma, Palomera, Luis, Marzo, Isabel, Naval, Javier, Villalba, Martín, Anel, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834301/
https://www.ncbi.nlm.nih.gov/pubmed/35159200
http://dx.doi.org/10.3390/cells11030392

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834301/
https://www.ncbi.nlm.nih.gov/pubmed/35159200
http://dx.doi.org/10.3390/cells11030392

Ejemplares similares